Kailera Therapeutics, Inc. (KLRA)
16.54
-0.63
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Kailera Therapeutics Shareholders Equity (Quarterly) : 1.118B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.118B |
| Date | Value |
|---|---|
| March 31, 2026 | 560.28M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Moderna, Inc. | 6.761B |
| Revolution Medicines, Inc. | 2.606B |
| Sana Biotechnology, Inc. | 154.57M |
| Parabilis Medicines, Inc. | 1.048B |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.211B |
| Total Liabilities (Quarterly) | 92.95M |
| Debt to Equity Ratio | 0.0091 |
| Current Ratio | 11.11 |